Henry Ford Cancer Institute/Henry Ford Health System is a clinical research site located in Detroit, Michigan, United States 48202.
Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.
Henry Ford Cancer Institute/Henry Ford Health System has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Head and Neck Squamous Cell Carcinoma (HNSCC), Non Small Cell Lung Cancer, KRAS Activating Mutation.
Sponsors: Regeneron Pharmaceuticals, Verastem, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Detroit
Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Henry Ford Cancer Institute/Henry Ford Health System has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Henry Ford Cancer Institute/Henry Ford Health System has 3 clinical trials on record, with 2 currently active. Their work covers Head and Neck Squamous Cell Carcinoma (HNSCC), Non Small Cell Lung Cancer, KRAS Activating Mutation.
Henry Ford Cancer Institute/Henry Ford Health System has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.